We provide a wide range of radiotherapy techniques and highly specialised services (stereotactic radiosurgery, interstitial brachytherapy). We are internationally prominent in certain core areas, such as brachytherapy and stereotactic radiotherapy, and are thereby acknowledged partners in oncology care.
In our Centre for Brachytherapy, our committed and specialised team provides all forms of brachytherapy, including intraoperative radiotherapy (IORT). In brachytherapy, a tiny radiation source is placed directly in the tumour, which gives the surrounding tissues the maximal protection. In particular, thanks to our experience and expertise, we are able to provide our patients with this additional therapeutic option for interstitial partial breast irradiation for carcinoma of the breast.
In the Centre for Stereotactic Radiotherapy, the stereotaxis team treats tumours using the most advanced technology and with the highest level of precision. Two state-of-the-art treatment systems are available: the LINAC-based Novalis TX® (LINAC-based) and the CyberKnife®, a dedicated stereotaxis unit. Both systems allow the adjustment of the patient’s position in six spatial directions and options for respiration-triggered radiotherapy of moving organs. The CyberKnife® also has the option of tumour tracking in real time for the treatment of various pulmonary and hepatic tumours.
Together with our high-quality service, we conduct extensive research programmes in the fields of clinical research, the development of technology, medical physics and radiobiology. By means of training and further education programmes for all involved professional groups (physicians, medical physicists, MTRA, nursing care), we continually reinforce our expertise and make an active contribution to high-quality care and the further development of radio-oncology.
Together with our alliance partners, we operate a clinical network unique in Switzerland and in this way make possible a comprehensive range of university-based radiotherapy with a high number of cases.